Fig. 18
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Anticancer screening results against HCT116 cancer cell line
Fig. 18 | BMC Chemistry
From: In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
Anticancer screening results against HCT116 cancer cell line